This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structure, featuring both an amino group and a difluoropyrrolidine moiety, makes it valuable for developing drugs targeting neurological disorders and psychiatric conditions. It is particularly significant in the creation of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) agents. Additionally, its unique properties enable its use in the design of small molecule inhibitors for enzymes involved in disease pathways, contributing to advancements in medicinal chemistry and drug discovery.